PMID- 27694988 OWN - NLM STAT- MEDLINE DCOM- 20180615 LR - 20181113 IS - 2045-2322 (Electronic) IS - 2045-2322 (Linking) VI - 6 DP - 2016 Oct 3 TI - Monosodium urate crystal-induced pro-interleukin-1beta production is post-transcriptionally regulated via the p38 signaling pathway in human monocytes. PG - 34533 LID - 10.1038/srep34533 [doi] LID - 34533 AB - IL-1beta is a key mediator of sterile inflammation in response to endogenous particulates, a type of damage-associated molecular pattern (DAMPs) molecule derived from damaged cells. Despite the well-known role of sterile particulates such as monosodium urate (MSU) crystals as inflammasome inducers in monocytes/macrophages, little is known regarding how pro-IL-1beta synthesis is induced under sterile inflammatory conditions. We provide evidence that MSU crystals post-transcriptionally induce the rapid production of pro-IL-1beta in human primary monocytes. Metabolic labeling and pull-down assays for newly-synthesized proteins clearly showed that MSU crystals rapidly, within 30 min, induce the synthesis of pro-IL-1beta as well as global proteins. Notably, MSU crystal-induced pro-IL-1beta synthesis is selectively dependent on the p38 MAPK pathway, whereas global protein synthesis is mediated via the mTOR, ERK1/2, and p38 pathways. Furthermore, inhibition of Mnk1, a substrate of p38, blocked MSU crystal-induced pro-IL-1beta synthesis downstream of eIF4E phosphorylation. In addition, the p38 MAPK pathway leading to phosphorylation of MK2 was also critical for stabilization of pro-IL-1beta mRNA following MSU stimulation. Our findings demonstrate that post-transcriptional regulation via p38 MAPK plays a central role in the rapid synthesis of pro-IL-1beta in response to MSU crystals, which is an essential step for IL-1beta production in human monocytes. FAU - Chung, Yeon-Ho AU - Chung YH AD - Department of Biomedical Sciences, and BK21Plus Biomedical Science Project, Seoul National University College of Medicine, 103 Daehak-ro, Jongno-gu, Seoul 110-799, South Korea. FAU - Kim, Dong-Hyun AU - Kim DH AD - Department of Biomedical Sciences, and BK21Plus Biomedical Science Project, Seoul National University College of Medicine, 103 Daehak-ro, Jongno-gu, Seoul 110-799, South Korea. FAU - Lee, Won-Woo AU - Lee WW AD - Department of Biomedical Sciences, and BK21Plus Biomedical Science Project, Seoul National University College of Medicine, 103 Daehak-ro, Jongno-gu, Seoul 110-799, South Korea. AD - Department of Microbiology and Immunology, Seoul National University College of Medicine, 103 Daehak-ro, Jongno-gu, Seoul 110-799, South Korea. AD - Cancer Research Institute, Ischemic/Hypoxic Disease Institute, and Institute of Infectious Diseases, Seoul National University College of Medicine; Seoul National University Hospital Biomedical Research Institute, 103 Daehak-ro, Jongno-gu, Seoul 110-799, South Korea. LA - eng PT - Journal Article PT - Research Support, Non-U.S. Gov't DEP - 20161003 PL - England TA - Sci Rep JT - Scientific reports JID - 101563288 RN - 0 (Interleukin-1) RN - 0 (Protein Precursors) RN - 0 (interleukin 1 precursor) RN - 268B43MJ25 (Uric Acid) RN - EC 2.7.11.24 (p38 Mitogen-Activated Protein Kinases) SB - IM MH - Female MH - Humans MH - Interleukin-1/*biosynthesis MH - MAP Kinase Signaling System/*drug effects MH - Male MH - Monocytes/*metabolism MH - Protein Precursors/*biosynthesis MH - Uric Acid/*pharmacology MH - p38 Mitogen-Activated Protein Kinases/*metabolism PMC - PMC5046103 EDAT- 2016/10/04 06:00 MHDA- 2018/06/16 06:00 PMCR- 2016/10/03 CRDT- 2016/10/04 06:00 PHST- 2016/04/14 00:00 [received] PHST- 2016/09/15 00:00 [accepted] PHST- 2016/10/04 06:00 [entrez] PHST- 2016/10/04 06:00 [pubmed] PHST- 2018/06/16 06:00 [medline] PHST- 2016/10/03 00:00 [pmc-release] AID - srep34533 [pii] AID - 10.1038/srep34533 [doi] PST - epublish SO - Sci Rep. 2016 Oct 3;6:34533. doi: 10.1038/srep34533.